Prostate cancer Board decisions

The Veteran's service connection for prostate cancer is denied, and his rating in excess of 50 percent for depressive disorder is also denied. However, the Veteran was granted compensation for total disability based on individual unemployability due to service-connected disabilities.

The Veteran's prostate cancer, which he claims is due to herbicide exposure during service in Korea, was denied as there is no evidence of herbicide exposure and the Veteran did not meet any qualifications for presumptive exposure.

The Veteran's appeal is remanded for further evaluation of his service-connected conditions, including PTSD and prostate cancer. The Board finds that the Veteran cannot secure or follow a substantially gainful occupation due to his physical disabilities.

The Veteran's PTSD symptoms are manifested by occupational and social impairment with deficiencies in most areas, such as work, school, family relations, judgment, thinking and/or mood. A disability rating of 70 percent for PTSD is granted.,Service connection for PTSD is granted effective November 24, 2015.,The Veteran's TDIU claim is granted based on his service-connected PTSD.,Service connection for hypertension is denied as there is no current diagnosis of hypertension in the record.,Service connection for obstructive sleep apnea (Insomnia) is remanded due to lack of evidence and need for a VA opinion.,Service connection for diabetes mellitus is remanded due to lack of evidence and need for a VA opinion.,Service connection for prostate cancer is remanded due to lack of evidence and need for a VA opinion.,Service connection for genitourinary disorder, to include BPH, is remanded due to lack of evidence and need for a VA opinion.,Service connection for flat feet is remanded due to lack of evidence and need for a VA opinion.

The Veteran's claim for hypertension is granted as it is presumed due to herbicide exposure under the PACT Act.,The effective date of service connection for CAD is set at March 1, 2017. The earlier effective dates for prostate cancer and its residuals (ED with SMC and a prostatectomy scar) are also granted based on the liberalizing law that added these conditions to presumptive service connection due to herbicide exposure.,The Veteran's claim for ED is granted as secondary to his service-connected prostate cancer, with an effective date of March 1, 2017.

The Veteran is granted service connection for prostate cancer, diabetes mellitus, and bladder cancer due to presumed exposure to herbicide agents during his military service.,The Veteran's cause of death was also found to be related to his service-connected prostate cancer.

The Veteran's residuals from prostate cancer resulted in nighttime awakening to void five or more times per night, which is equivalent to a 40% rating. The Veteran was denied a higher rating as there was no evidence of renal dysfunction or the use of absorbent materials or an appliance.

The Board has found that the VA examinations did not substantially comply with the remand directives and have ordered additional development for both the bilateral wrist carpal tunnel syndrome claim and the prostate cancer claim.

The Board has denied the Veteran's claims for service connection for cervical pain, lower back disability, bilateral foot disability, bronchitis, hypertension, stomach injury, ulcer disease, prostate cancer, erectile dysfunction, and bilateral hearing loss. The Board found that there was no evidence of a chronic condition during or within one year after service, and that any current conditions are not related to service.

The Board has granted service connection for ischemic heart disease, multiple myeloma, prostate cancer, and soft tissue sarcoma on a presumptive basis due to in-service exposure to herbicide agents. Service connection for carcinoma is remanded as there was not sufficient evidence provided by the RO.

The Board has found a duty to assist error occurred and remands the case for further examination to differentiate between symptoms due to service-connected prostate cancer and non-service-connected neurogenic bladder.

The Veteran's service-connected disabilities do not require the care or assistance of another on a regular basis and do not render him housebound, thus his claim for special monthly compensation (SMC) based on aid and attendance and/or by being housebound is denied.

The Veteran's prostate cancer and coronary artery disease are granted service connection as they are related to his military service.

The Veteran's service-connected disabilities did not render him unable to secure or follow substantially gainful employment during the appeal period, leading to a denial of his claim for total disability rating based upon individual unemployability.

The rating reduction from 100 percent to 10 percent for service-connected residuals of prostate cancer, effective May 1, 2021, was proper. The Veteran's disability rating is being remanded due to the need for a VA examination to determine the current severity of his service-connected prostate cancer residuals.

The Veteran was granted a total disability rating for compensation purposes based on individual unemployability due to service-connected prostate cancer residuals from June 1, 2018.

The Veteran's prostate cancer is currently rated at 40 percent, effective November 1, 2016. The Board has determined that a remand is necessary to obtain updated medical records and an examination to evaluate the severity of his prostate cancer.

The appeal for service connection of diabetes mellitus is dismissed. The Board has remanded the issues regarding a higher rating for voiding dysfunction and an earlier effective date for SMC.

The Board dismissed the claim for service connection of a right shoulder disability as it was not intended by the Veteran.,The Board denied the request to revise or reverse the September 2016 rating decision regarding prostate cancer on grounds of CUE, finding no evidence of duty-to-assist error and that the claim should have been granted at the outset.

The Veteran's initial claim for a compensable rating for prostate cancer in remission is being remanded due to an error in obtaining relevant private treatment records.